Cytoreduction and Hyperthermic Intrathoracic Chemotherapy for Metastatic Pseudomyxoma Peritonei

Luke J. Matzek, MD; Jaelin J. Otta, MD; Ryan E. Hofer, MD; Charles R. Sims, 3rd, MD; Mitchell J. Kerfeld, MD; Thomas M. Stewart, MD; Travis E. Grotz, MD; Luis F. Tapias, MD

Annals of Thoracic Surgery Short Reports (Sep 2024)

Cytoreduction and Hyperthermic Intrathoracic Chemotherapy for Metastatic Pseudomyxoma Peritonei

Luke J. Matzek, MD,
Jaelin J. Otta, MD,
Ryan E. Hofer, MD,
Charles R. Sims, 3rd, MD,
Mitchell J. Kerfeld, MD,
Thomas M. Stewart, MD,
Travis E. Grotz, MD,
Luis F. Tapias, MD

Affiliations

Luke J. Matzek, MD: Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota; Division of Critical Care Medicine, Mayo Clinic, Rochester, Minnesota
Jaelin J. Otta, MD: Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota
Ryan E. Hofer, MD: Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota
Charles R. Sims, 3rd, MD: Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota; Division of Critical Care Medicine, Mayo Clinic, Rochester, Minnesota
Mitchell J. Kerfeld, MD: Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota
Thomas M. Stewart, MD: Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota
Travis E. Grotz, MD: Division of Hepatobiliary and Pancreatic Surgery, Mayo Clinic, Rochester, Minnesota
Luis F. Tapias, MD: Division of Thoracic Surgery, Mayo Clinic, Rochester, Minnesota; Address correspondence to Dr Tapias, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905.

Journal volume & issue: Vol. 2, no. 3
pp. 520 – 523

Abstract

Read online

Pleural extension of pseudomyxoma peritonei is rare, and treatment demands multidisciplinary care. Perioperative management during cytoreductive surgery and hyperthermic intrathoracic chemotherapy challenges anesthesiology and surgical teams in unique ways. Hemodynamic, arrhythmogenic, ventilatory, fluid balance, acid-base, and nephroprotection issues are important considerations. The use of cytoreductive surgery and hyperthermic intrathoracic chemotherapy for extraperitoneal pseudomyxoma peritonei is an innovative and potentially curative approach. Here, we describe our approach to managing these patients.

Published in Annals of Thoracic Surgery Short Reports

ISSN: 2772-9931 (Online)
Publisher: Elsevier
Country of publisher: United States
LCC subjects: Medicine: Surgery; Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
Website: https://www.sciencedirect.com/journal/annals-of-thoracic-surgery-short-reports

About the journal